Citadel Advisors
ESMC

Citadel Advisors’s Escalon Medical Corp ESMC Stock Holding History

Citadel Advisors’s Portfolio ESMC Stock Details ESMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-51,984
Closed -$35K – 8334
2016
Q3 		$35K Buy
51,984
+32,238
+163% +$23.3K ﹤0.01% 6935
2016
Q2 		$13K Sell
19,746
-1,216
-6% -$935 ﹤0.01% 6709
2016
Q1 		$17K Buy
20,962
+4,287
+26% +$3.97K ﹤0.01% 6528
2015
Q4 		$19K Buy
16,675
+5,358
+47% +$5.86K ﹤0.01% 7988
2015
Q3 		$12K Sell
11,317
-1,363
-11% -$1.77K ﹤0.01% 8418
2015
Q2 		$18K Buy
12,680
+24
+0.2% +$33 ﹤0.01% 8216
2015
Q1 		$17K Sell
12,656
-1,321
-9% -$1.91K ﹤0.01% 8021
2014
Q4 		$23K Buy
+13,977
New +$20K ﹤0.01% 7717
2014
Q2 		– Sell
-17,320
Closed -$27K – 8572
2014
Q1 		$27K Buy
+17,320
New +$30.6K ﹤0.01% 7154
2013
Q3 		– Sell
-10,430
Closed -$13K – 7000
2013
Q2 		$13K Buy
+10,430
New +$12.4K ﹤0.01% 6184

Other funds holding ESMC

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Citadel Advisors's ESMC Position: Q4 2016 in Review

Citadel Advisors sold out of Escalon Medical Corp (ESMC) in Q4 2016, closing a stake of 51,984 shares — an estimated $35K sold.

Citadel Advisors first reported a position in ESMC in Q2 2013 and held it in 10 quarters. The position peaked at $35K in Q3 2016. 3 funds tracked by Wall St. Rank hold ESMC as of Q4 2016.

  • Citadel Advisors reported no remaining Escalon Medical Corp position as of Q4 2016 after selling out during the quarter.
  • Citadel Advisors sold 51,984 Escalon Medical Corp shares in Q4 2016, an estimated $35K.
  • Citadel Advisors first reported a position in Escalon Medical Corp in Q2 2013 and held it in 10 quarters.
  • Citadel Advisors's Escalon Medical Corp position peaked at $35K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q4 2016.

Based on Citadel Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.